The long term goals are to relate the electrical activity of the heart to the genesis and processing of the ion channels responsible for this activity.
The specific aims are to: 1) study processing of HERG using misprocessed mutants linked to hLQT2 as probes; 2) test for native chaperones that may interact with HERG during processing and characterize a novel ER resident protein recently discovered by us to interact directly with HERG; 3) expand upon our recent discovery of a novel cytoplasmic protein member of a family of K+ channel chaperones that enhances HERG currents and may be useful as a chaperone to rescue misprocessed mutants; and 4) study the interactions between KvLQT1 and minK during processing using misprocessed mutants linked to hereditary long QT syndrome (hLQTS) as probes. The mutations in KvLQT1/minK and HERG are responsible for most cases of hLQTS and HERG is the target in the majority of cases of the more common acquired LQTS produced by cardiac and non-cardiac anti-arrhythmic drugs. An important outcome of our studies will be the identification of trafficking mutants in hLQTS and the discovery of agents which may enhance trafficking of mutant channels. Likewise we may identify drugs which alter trafficking of normal channels to reduce or increase currents thereby mimicking channel blockers or channel activators. The research uses misprocessed mutant HERG and KvLQT1/minK channels to identify sites along the processing pathway are critical for maturation and trafficking and conversely searches for processing proteins that interact with wild type and mutant channels. The methods include patch clamp electrophysiology, immunostaining, immunoblotting, immunopurification, pulse-chase labeling, mutagenesis, and yeast two hybrid screens. Our strategy has already led to the discovery of a novel ER-resident protein that interacts with HERG and a novel cytoplasmic protein that enhances HERG currents. Their mechanisms of action together with characterizing the processing of HERG and KvLQT1/minK are the goals of this proposal.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL036930-16
Application #
6200201
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1985-12-01
Project End
2004-07-31
Budget Start
2000-09-05
Budget End
2001-07-31
Support Year
16
Fiscal Year
2000
Total Cost
$303,000
Indirect Cost
Name
Case Western Reserve University
Department
Physiology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Kuryshev, Yuri A; Ficker, Eckhard; Wang, Lu et al. (2005) Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther 312:316-23
Brown, Arthur M (2005) HERG block, QT liability and sudden cardiac death. Novartis Found Symp 266:118-31; discussion 131-5, 155-8
Brown, A M (2004) Drugs, hERG and sudden death. Cell Calcium 35:543-7
Ficker, Eckhard; Kuryshev, Yuri A; Dennis, Adrienne T et al. (2004) Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 66:33-44
Ficker, Eckhard; Dennis, Adrienne T; Wang, Lu et al. (2003) Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res 92:e87-100
Obejero-Paz, Carlos A; Yang, Tianen; Dong, Wei-Qiang et al. (2003) Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy. J Lab Clin Med 141:121-30
Laurita, Kenneth R; Chuck, Emil Thomas; Yang, Tianen et al. (2003) Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy. J Lab Clin Med 142:83-9
Schwalbe, Ruth A; Rudin, Alicia; Xia, Shen-Ling et al. (2002) Site-directed glycosylation tagging of functional Kir2.1 reveals that the putative pore-forming segment is extracellular. J Biol Chem 277:24382-9
Ficker, Eckhard; Obejero-Paz, Carlos A; Zhao, Shuxia et al. (2002) The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. J Biol Chem 277:4989-98
Wible, Barbara A; Wang, Liming; Kuryshev, Yuri A et al. (2002) Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3beta in prostate cancer cells. J Biol Chem 277:17852-62

Showing the most recent 10 out of 95 publications